Mineralocorticoid receptor blockade with finerenone improves heart function and exercise capacity in ovariectomized mice

AIMS: In post‐menopausal women, incidence of heart failure with preserved ejection fraction is higher than in men. Hormonal replacement therapies did not demonstrate benefits. We tested whether the non‐steroidal mineralocorticoid receptor antagonist finerenone limits the progression of heart failure...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:ESC Heart Fail
Päätekijät: Pieronne‐Deperrois, Marie, Guéret, Alexandre, Djerada, Zoubir, Crochemore, Clément, Harouki, Najah, Henry, Jean‐Paul, Dumesnil, Anaïs, Larchevêque, Marine, do Rego, Jean‐Claude, do Rego, Jean‐Luc, Nicol, Lionel, Richard, Vincent, Jaisser, Frédéric, Kolkhof, Peter, Mulder, Paul, Monteil, Christelle, Ouvrard‐Pascaud, Antoine
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2021
Aiheet:
Original Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8120350/
https://ncbi.nlm.nih.gov/pubmed/33742556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13219
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia